Fort Point Capital Partners LLC Abbott Laboratories Transaction History

Fort Point Capital Partners LLC

$794 Million
Q3 2025

A detailed history of Fort Point Capital Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 6,435 shares of ABT stock, worth $836,743. This represents 0.11% of its overall portfolio holdings.

Number of Shares

6,435

Previous 7,249 11.23%

Holding current value

$836,743

Previous $985,000 12.59%

% of portfolio

0.11%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$120.51 - $136.62 $98,095 - $111,208	-814 Reduced 11.23%	6,435 $861,000
Q2 2025 Aug 14, 2025	BUY	$123.95 - $138.08 $5,825 - $6,489	47 Added 0.65%	7,249 $985,000
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $48,106 - $60,715	-433 Reduced 5.67%	7,202 $955,000
Q4 2024 Feb 11, 2025	BUY	$111.93 - $119.39 $148,978 - $158,908	1,331 Added 21.11%	7,635 $863,000
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $38,627 - $45,598	386 Added 6.52%	6,304 $718,000

Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $33,341 - $37,217	331 Added 5.92%	5,918 $614,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $32,636 - $36,046	298 Added 5.63%	5,587 $635,000
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $631 - $772	7 Added 0.13%	5,289 $582,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $93,725 - $104,429	-930 Reduced 14.97%	5,282 $575,000
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $6,877 - $8,094	71 Added 1.16%	6,212 $629,000
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $28,737 - $33,272	297 Added 5.08%	6,141 $594,000
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $33,989 - $41,082	-333 Reduced 5.39%	5,844 $635,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $114,020 - $139,040	1,000 Added 19.32%	6,177 $731,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $26,481 - $29,296	227 Added 4.59%	5,177 $612,000
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $17,325 - $18,879	165 Added 3.45%	4,950 $542,000
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $16,953 - $20,588	-185 Reduced 3.72%	4,785 $521,000
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $22,894 - $29,302	-299 Reduced 5.67%	4,970 $454,000
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $1,130 - $1,653	-18 Reduced 0.34%	5,269 $416,000
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $26,928 - $29,978	343 Added 6.94%	5,287 $459,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $66,208 - $71,790	809 Added 19.56%	4,944 $414,000
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $23,772 - $28,741	-359 Reduced 7.99%	4,135 $331,000
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $11,538 - $13,071	-176 Reduced 3.77%	4,494 $325,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1,277 - $1,540	21 Added 0.45%	4,670 $343,000
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $37,132 - $40,983	645 Added 16.11%	4,649 $284,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $28,922 - $32,700	-514 Reduced 11.38%	4,004 $240,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $242,526 - $259,649	4,518	4,518 $258,000

Others Institutions Holding ABT

# of Institutions

3,639

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.

Account

Fort Point Capital Partners LLC Abbott Laboratories Transaction History